Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment
Coronavirus disease-19 (COVID-19), caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic. The disease primarily spreads through respiratory droplets and manifests with a wide range of symptoms, from mild respiratory illness to sev...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Mazandaran
2025-01-01
|
| Series: | Journal of Genetic Resources |
| Subjects: | |
| Online Access: | https://sc.journals.umz.ac.ir/article_5430_c085e75bee58d81f05c196d6666407fb.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849721583304704000 |
|---|---|
| author | Somayeh Arabzadeh Sohameh Mohebbi Zahra Faal Neda Jalali Kayvan Saeedfar |
| author_facet | Somayeh Arabzadeh Sohameh Mohebbi Zahra Faal Neda Jalali Kayvan Saeedfar |
| author_sort | Somayeh Arabzadeh |
| collection | DOAJ |
| description | Coronavirus disease-19 (COVID-19), caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic. The disease primarily spreads through respiratory droplets and manifests with a wide range of symptoms, from mild respiratory illness to severe pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. The virus manipulates the host cell cycle to create a favorable environment for its replication and propagation. One of the key regulators of the cell cycle is cyclin-D, a protein essential for the G1 to S phase transition in the cell cycle, and P53, a critical tumor suppressor and regulator of cell cycle arrest and apoptosis. Therapeutic strategies, including antiviral drugs like Remdesivir, have shown varying efficacy in managing symptoms and reducing mortality. This study obtained blood samples from 30 COVID-19 patients before and after Remdesivir treatment and 20 healthy individuals. RNA was isolated, and cDNA was subsequently synthesized. The expression levels of the p53 and cyclin-D genes were then assessed using Real-time PCR. The results demonstrate that cyclin-D expression increased 9 times in COVID-19 patients compared to the control group (P<0.001), which remained unaffected by Remdesivir treatment. Conversely, p53 gene expression was reduced by 50% in the patient group compared to the control group (P<0.05). Treatment with Remdesivir increased P53 gene expression twofold compared to the control group (P<0.001). Furthermore, P53 gene expression positively correlated with CRP (C Reactive Protein) levels in both the control and patient groups (P<0.01). The study's findings indicate that certain symptoms of COVID-19 may be linked to the virus's impact on crucial cell cycle genes, such as cyclin-D and p53. Remdesivir, by reducing inflammation and inhibiting viral replication, can help restore normal expression levels of these genes. This may support the therapeutic benefits of using Remdesivir in treating COVID-19. |
| format | Article |
| id | doaj-art-e1a0d3228286435c98f451d48a1786b6 |
| institution | DOAJ |
| issn | 2423-4257 2588-2589 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | University of Mazandaran |
| record_format | Article |
| series | Journal of Genetic Resources |
| spelling | doaj-art-e1a0d3228286435c98f451d48a1786b62025-08-20T03:11:38ZengUniversity of MazandaranJournal of Genetic Resources2423-42572588-25892025-01-01111213010.22080/jgr.2025.28440.14215430Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir TreatmentSomayeh Arabzadeh0Sohameh Mohebbi1Zahra Faal2Neda Jalali3Kayvan Saeedfar4Department of Biology, Faculty of Basic science, Ale Taha institute of higher education, Tehran, IranDepartment of Biology, Faculty of Basic Science, Ale Taha Institute of Higher Education, Tehran, Iran.Department of Biology, Faculty of Basic Science, Ale Taha Institute of Higher Education, Tehran, Iran.Department of Biology, Faculty of Basic Science, Ale Taha Institute of Higher Education, Tehran, Iran.Tracheal Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, IranCoronavirus disease-19 (COVID-19), caused by the new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic. The disease primarily spreads through respiratory droplets and manifests with a wide range of symptoms, from mild respiratory illness to severe pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure. The virus manipulates the host cell cycle to create a favorable environment for its replication and propagation. One of the key regulators of the cell cycle is cyclin-D, a protein essential for the G1 to S phase transition in the cell cycle, and P53, a critical tumor suppressor and regulator of cell cycle arrest and apoptosis. Therapeutic strategies, including antiviral drugs like Remdesivir, have shown varying efficacy in managing symptoms and reducing mortality. This study obtained blood samples from 30 COVID-19 patients before and after Remdesivir treatment and 20 healthy individuals. RNA was isolated, and cDNA was subsequently synthesized. The expression levels of the p53 and cyclin-D genes were then assessed using Real-time PCR. The results demonstrate that cyclin-D expression increased 9 times in COVID-19 patients compared to the control group (P<0.001), which remained unaffected by Remdesivir treatment. Conversely, p53 gene expression was reduced by 50% in the patient group compared to the control group (P<0.05). Treatment with Remdesivir increased P53 gene expression twofold compared to the control group (P<0.001). Furthermore, P53 gene expression positively correlated with CRP (C Reactive Protein) levels in both the control and patient groups (P<0.01). The study's findings indicate that certain symptoms of COVID-19 may be linked to the virus's impact on crucial cell cycle genes, such as cyclin-D and p53. Remdesivir, by reducing inflammation and inhibiting viral replication, can help restore normal expression levels of these genes. This may support the therapeutic benefits of using Remdesivir in treating COVID-19.https://sc.journals.umz.ac.ir/article_5430_c085e75bee58d81f05c196d6666407fb.pdfcell cyclecovid-19cyclin-dp53remdesivir |
| spellingShingle | Somayeh Arabzadeh Sohameh Mohebbi Zahra Faal Neda Jalali Kayvan Saeedfar Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment Journal of Genetic Resources cell cycle covid-19 cyclin-d p53 remdesivir |
| title | Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment |
| title_full | Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment |
| title_fullStr | Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment |
| title_full_unstemmed | Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment |
| title_short | Assessment of Alterations in the Expression of P53 and Cyclin-D Genes in COVID-19 Patients Before and After Remdesivir Treatment |
| title_sort | assessment of alterations in the expression of p53 and cyclin d genes in covid 19 patients before and after remdesivir treatment |
| topic | cell cycle covid-19 cyclin-d p53 remdesivir |
| url | https://sc.journals.umz.ac.ir/article_5430_c085e75bee58d81f05c196d6666407fb.pdf |
| work_keys_str_mv | AT somayeharabzadeh assessmentofalterationsintheexpressionofp53andcyclindgenesincovid19patientsbeforeandafterremdesivirtreatment AT sohamehmohebbi assessmentofalterationsintheexpressionofp53andcyclindgenesincovid19patientsbeforeandafterremdesivirtreatment AT zahrafaal assessmentofalterationsintheexpressionofp53andcyclindgenesincovid19patientsbeforeandafterremdesivirtreatment AT nedajalali assessmentofalterationsintheexpressionofp53andcyclindgenesincovid19patientsbeforeandafterremdesivirtreatment AT kayvansaeedfar assessmentofalterationsintheexpressionofp53andcyclindgenesincovid19patientsbeforeandafterremdesivirtreatment |